We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+15.2%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.07B
AUM Growth
+$251M
Cap. Flow
-$68.7M
Cap. Flow %
-3.32%
Top 10 Hldgs %
44.01%
Holding
2,647
New
722
Increased
455
Reduced
467
Closed
877

Sector Composition

Rank Sector Weight
1 Technology 6.57%
2 Consumer Discretionary 4.71%
3 Industrials 3.64%
4 Healthcare 3.58%
5 Communication Services 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNET icon
326
TriNet
TNET
$3.14B
$746K 0.04%
12,580
+5,479
+77% +$352K
MDP
327
DELISTED
Meredith Corporation
MDP
$746K 0.04%
56,896
+4,621
+9% +$64.6K
RETA
328
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$745K 0.04%
7,652
+7,267
+1,888% +$908K
EFOR
329
Everforth Inc
EFOR
$1.34B
$743K 0.04%
11,696
+4,737
+68% +$326K
TMHC
330
DELISTED
Taylor Morrison
TMHC
$743K 0.04%
+30,216
New +$714K
DXCM icon
331
DexCom
DXCM
$33.1B
$739K 0.04%
7,168
+1,924
+37% +$201K
TQQQ icon
332
CALL
ProShares UltraPro QQQ
TQQQ
$37.3B
$733K 0.04%
44,800
-2,400
-5% -$37.8K
DADA
333
DELISTED
Dada Nexus
DADA
$731K 0.04%
27,610
+23,024
+502% +$600K
GS icon
334
Goldman Sachs
GS
$301B
$723K 0.04%
+3,597
New +$732K
CERN
335
DELISTED
Cerner Corp
CERN
$723K 0.04%
+10,008
New +$713K
FATE icon
336
Fate Therapeutics
FATE
$323M
$720K 0.03%
18,021
+2,573
+17% +$89.8K
INFO
337
DELISTED
IHS Markit Ltd. Common Shares
INFO
$715K 0.03%
+9,104
New +$725K
RSP icon
338
PUT
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
$714K 0.03%
+6,600
New +$712K
HCSG icon
339
Healthcare Services Group
HCSG
$1.52B
$713K 0.03%
+33,123
New +$773K
TSN icon
340
Tyson Foods
TSN
$20.3B
$712K 0.03%
+11,973
New +$738K
BILL icon
341
BILL Holdings
BILL
$4.84B
$710K 0.03%
7,074
-4,976
-41% -$453K
CLGX
342
DELISTED
Corelogic, Inc.
CLGX
$710K 0.03%
10,490
+9,171
+695% +$617K
SPLK
343
DELISTED
Splunk Inc
SPLK
$709K 0.03%
3,770
-1,772
-32% -$353K
AMN icon
344
PUT
AMN Healthcare
AMN
$1.42B
$702K 0.03%
+12,000
New +$632K
AMN icon
345
AMN Healthcare
AMN
$1.42B
$699K 0.03%
+11,962
New +$630K
VALE icon
346
Vale
VALE
$63.3B
$698K 0.03%
+66,000
New +$741K
AVGO icon
347
PUT
Broadcom
AVGO
$2.02T
$692K 0.03%
19,000
-172,000
-90% -$5.76M
LPX icon
348
Louisiana-Pacific
LPX
$5.24B
$690K 0.03%
23,394
-31,487
-57% -$967K
DGX icon
349
PUT
Quest Diagnostics
DGX
$26.2B
$687K 0.03%
+6,000
New +$709K
NXPI icon
350
NXP Semiconductors
NXPI
$59.5B
$686K 0.03%
5,500
+5,317
+2,905% +$649K

Similar funds

Prelude Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Prelude Capital Management held 2,647 positions worth $2.07B, up 14% from $1.82B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Prelude Capital Management withdrew a net $68.7M in Q3 2020, closing 877 positions and reducing 467 holdings. Its most notable exit was Invesco QQQ Trust, an estimated $9.18M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.6% of assets, down from 7% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Prelude Capital Management opened a new position in Equitrans Midstream Corporation Common Stock worth $14.9M.

  • Prelude Capital Management's largest Q3 2020 buy was Equitrans Midstream Corporation Common Stock: 1,760,179 shares worth $14.9M.
  • Prelude Capital Management added most to Alibaba in Q3 2020, an estimated $12.1M increase.
  • Prelude Capital Management's biggest Q3 2020 reduction was Broadcom, cutting an estimated $5.72M.
  • Prelude Capital Management fully exited Invesco QQQ Trust in Q3 2020, selling an estimated $9.18M.
  • Prelude Capital Management's ten largest holdings make up 44% of its $2.07B portfolio in Q3 2020.
  • Prelude Capital Management opened 722 new positions and closed 877 in Q3 2020.
  • Prelude Capital Management's portfolio value rose 14% quarter-over-quarter to $2.07B.

Based on Prelude Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.